Get the Stockscreener App
197.55
1.37%
-2.74
After Hours:
199.78
2.23
+1.13%
Molina Healthcare Inc stock is traded at $197.55, with a volume of 1.34M.
It is down -1.37% in the last 24 hours and down -1.92% over the past month.
Molina Healthcare Inc provides medical insurance plans through Medicaid, the individual exchanges, and Medicare. The company operates in four reportable segments consisting of: 1) Medicaid; 2) Medicare; 3) Marketplace; and 4) Other. It manages health benefit risks for more than 5 million people, with more than 85% of those members coming through contracts with state governments for their Medicaid programs. Medicaid contracts in four states-California, New York, Texas, and Washington-account for over half of its enrollees.
See More
Previous Close:
$200.29
Open:
$198.33
24h Volume:
1.34M
Relative Volume:
1.03
Market Cap:
$10.31B
Revenue:
$45.08B
Net Income/Loss:
$188.00M
P/E Ratio:
58.26
EPS:
3.3907
Net Cash Flow:
$251.00M
1W Performance:
-12.34%
1M Performance:
-1.92%
6M Performance:
-2.15%
1Y Performance:
+24.86%
1-Day Range:
$193.29
$200.26
1-Week Range:
$192.29
$233.27
52-Week Range:
$121.06
$244.89
Molina Healthcare Inc Stock (MOH) Company Profile
Name
Molina Healthcare Inc
Sector
Industry
Phone
(562) 435-3666
Address
200 OCEANGATE, SUITE 100, LONG BEACH, CA
Compare MOH vs UNH, CVS, ELV, CI, HUM
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MOH
Molina Healthcare Inc
|
197.55 | 10.46B | 45.08B | 188.00M | 251.00M | 3.3907 |
UNH
Unitedhealth Group Inc
|
420.74 | 384.65B | 450.13B | 14.91B | 23.62B | 15.55 |
CVS
Cvs Health Corp
|
107.74 | 136.38B | 407.94B | 2.90B | 7.39B | 2.2771 |
ELV
Elevance Health Inc
|
377.68 | 82.26B | 201.11B | 4.95B | 6.29B | 22.50 |
CI
Cigna Group
|
289.57 | 75.73B | 278.13B | 6.74B | 7.66B | 23.60 |
HUM
Humana Inc
|
389.32 | 47.36B | 137.20B | 1.15B | 1.27B | 9.3439 |
Molina Healthcare Inc Stock (MOH) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-20-26 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Oct-24-25 | Downgrade | Barclays | Equal Weight → Underweight |
| Oct-16-25 | Downgrade | TD Cowen | Buy → Hold |
| Oct-14-25 | Initiated | Goldman | Neutral |
| Jul-25-25 | Downgrade | Cantor Fitzgerald | Overweight → Neutral |
| Jul-25-25 | Downgrade | Truist | Buy → Hold |
| Jul-10-25 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jun-09-25 | Initiated | Morgan Stanley | Overweight |
| Apr-22-25 | Initiated | Bernstein | Outperform |
| Apr-15-25 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-05-25 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Dec-17-24 | Resumed | JP Morgan | Neutral |
| May-30-24 | Initiated | Robert W. Baird | Outperform |
| Mar-28-24 | Downgrade | BofA Securities | Neutral → Underperform |
| Mar-06-24 | Initiated | Barclays | Equal Weight |
| Feb-15-24 | Upgrade | Wells Fargo | Underweight → Equal Weight |
| Jun-20-23 | Initiated | UBS | Neutral |
| Apr-21-23 | Initiated | Cantor Fitzgerald | Overweight |
| Dec-13-22 | Upgrade | BofA Securities | Underperform → Neutral |
| Oct-03-22 | Resumed | JP Morgan | Overweight |
| Jun-17-22 | Initiated | Loop Capital | Hold |
| May-26-22 | Downgrade | BofA Securities | Buy → Underperform |
| Dec-14-21 | Initiated | Goldman | Buy |
| Nov-22-21 | Resumed | Deutsche Bank | Hold |
| Sep-10-21 | Initiated | Cowen | Outperform |
| Jul-09-21 | Initiated | Seaport Global Securities | Neutral |
| May-19-21 | Initiated | Wells Fargo | Underweight |
| Mar-30-21 | Initiated | Credit Suisse | Outperform |
| Mar-10-21 | Initiated | Mizuho | Buy |
| Feb-19-21 | Resumed | Barclays | Overweight |
| Jan-21-21 | Initiated | Goldman | Neutral |
| Sep-22-20 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jul-01-20 | Resumed | SVB Leerink | Outperform |
| Jun-16-20 | Upgrade | Cowen | Market Perform → Outperform |
| Apr-14-20 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-20 | Upgrade | BofA/Merrill | Underperform → Buy |
| Oct-30-19 | Downgrade | Jefferies | Buy → Hold |
| Sep-12-19 | Initiated | Deutsche Bank | Buy |
| Jul-31-19 | Reiterated | BofA/Merrill | Underperform |
| Jun-03-19 | Upgrade | BMO Capital Markets | Market Perform → Outperform |
| May-31-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Apr-30-19 | Reiterated | BofA/Merrill | Underperform |
| Jan-14-19 | Initiated | Stephens | Equal-Weight |
| Jan-08-19 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-13-18 | Upgrade | Jefferies | Hold → Buy |
| Oct-12-18 | Downgrade | Jefferies | Buy → Hold |
| Oct-10-18 | Initiated | Evercore ISI | In-line |
| Jun-27-18 | Downgrade | JP Morgan | Overweight → Neutral |
| Jun-22-18 | Upgrade | Jefferies | Hold → Buy |
| Mar-28-18 | Reiterated | Leerink Partners | Outperform |
| Jan-16-18 | Upgrade | JP Morgan | Neutral → Overweight |
View All
Molina Healthcare Inc Stock (MOH) Latest News
Molina Healthcare, Inc. Q2 2026 Financial Results: Revenue, Earnings, and Market Insights from Form 10-Q - Minichart
Are Investors Undervaluing Molina Healthcare (MOH) Right Now? - Yahoo Finance
Deutsche Bank Adjusts Molina Healthcare Price Target to $147 From $129, Maintains Hold Rating - marketscreener.com
Truist Cuts Price Target on Molina Healthcare to $225 From $250, Keeps Hold Rating - marketscreener.com
Cantor Fitzgerald maintains Molina Healthcare stock rating at Neutral By Investing.com - Investing.com Canada
Cantor Fitzgerald maintains Molina Healthcare stock rating at Neutral - Investing.com
RBC Lowers Price Target on Molina Healthcare to $218 From $248, Keeps Sector Perform Rating - marketscreener.com
Molina Healthcare stock trades steadily as Medicaid and marketplace growth support margins - AD HOC NEWS
MOLINA HEALTHCARE INC : RBC CUTS TARGET PRICE TO $218 FROM $248 - Bitget
Bronstein, Gewirtz & Grossman, LLC Encourages Molina Healthcare, Inc. (MOH) Shareholders to Inquire about Securities Investigation - ACCESS Newswire
MOH5939488 Bond Risk Profile - TradingView
MOH5939488 Bond Coupon Profile — Rate & Payments - TradingView
Molina Healthcare Inc Stock 12‑Month Price Target Raised to $212.53, Implies 4% Downside - TradingView
Is Molina Healthcare Inc (MOH) a Bargain After 9.7% Drop? GF Val - GuruFocus
Molina Healthcare Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Molina Healthcare sharply cuts its Obamacare business as costs rise - marketscreener.com
Molina Healthcare Inc (MOH) Q2 2026 Earnings Call Highlights: St - GuruFocus
Molina Healthcare Inc (MOH) Q2 2026 Earnings Call Highlights: Strong Medicaid Performance Amid ... - Yahoo Finance
Molina Healthcare (MOH) Reports Strong Earnings but Shares Decli - GuruFocus
MOH Q2 Earnings Beat on Lower Operating Expenses, 2026 EPS View Raised - TradingView
Why Is Molina Healthcare Stock Sinking Thursday?Molina Healthcare (NYSE:MOH) - Benzinga
Molina plummets as it expects to halve its Obamacare presence - Reuters
Molina Faces Very High Uncertainty Around a Range of Potential Profit Scenarios - Morningstar
Molina Healthcare Announces Q2 2026 Financial Results and Updates on Investment Portfolio - Kalkine Media
Molina stock falls despite Q2 beat (MOH:NYSE) - Seeking Alpha
Form 10-Q MOLINA HEALTHCARE, INC. For: Jun 30 - StreetInsider
Molina Healthcare Tops Q2 2026 Profit Forecast With $1.51 EPS - AlphaStreet
Earnings call transcript: Molina Healthcare beats Q2 2026 EPS, shares fall premarket - Investing.com
Molina Healthcare, Inc. Q2 2026 Earnings Call Summary - Yahoo Finance
Molina Healthcare Releases Q2 2026 Financial Results - AlphaStreet
Molina Healthcare stock reacts to Medicaid margin focus after 2025 guidance update - AD HOC NEWS
Molina Healthcare Q2 EPS beats estimates on $10.874 billion sales - scanx.trade
Molina Healthcare Earnings Beat Estimates. The Medicaid Insurer Is Confronting Investor Doubts. -- Barrons.com - Moomoo
Molina Healthcare stock falls as first-half EPS covers 73.5% of 2026 floor - TechStock²
Molina Healthcare Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Molina Healthcare Boosts 2026 Full-Year Earnings Forecast After Strong Q2 Results - Kalkine Media
MOH5939488 Bond Profile — Key Metrics - TradingView
Is Molina Healthcare (MOH) Undervalued After Q2 Earnings Miss? G - GuruFocus
Molina Healthcare Q2 Adjusted Earnings, Revenue Fall; Shares Drop After Hours - marketscreener.com
Molina: Q2 Earnings Snapshot - 10TV
Molina Healthcare slides nearly 7% on weak revenue outlook despite topping Q2 estimates - Investing.com
Molina Healthcare (NYSE:MOH) Posts Q2 CY2026 Sales In Line With Estimates But Stock Drops On Weak Guidance - The Globe and Mail
Molina Healthcare (MOH) Earnings: Q2 Adjusted EPS Surpasses Estimates Amid Revenue Decline - Smartkarma
Earnings Flash (MOH) Molina Healthcare, Inc. Posts Q2 Adjusted EPS $1.51 per Share, vs. FactSet Est of $1.39 - marketscreener.com
Molina Healthcare Reports Second Quarter 2026 Financial Results - Business Wire
Molina Healthcare earnings in focus as guidance decision looms By Investing.com - Investing.com Nigeria
Molina Healthcare earnings in focus as guidance decision looms - Investing.com
Why Molina Healthcare (MOH) Is Down 6.2% After S&P Index Shift And Rising Profit Concerns - Sahm
Bronstein, Gewirtz & Grossman, LLC Is Investigating Molina Healthcare, Inc. (MOH) And Encourages Shareholders to Connect - ACCESS Newswire
Molina Healthcare, Inc.(NYSE: MOH) added to S&P 400 Health Care - marketscreener.com
Molina Healthcare, Inc.(NYSE: MOH) added to S&P 400 - marketscreener.com
Molina Healthcare Inc Stock (MOH) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.52%
0.44%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):